Inquiry Basket
Loading ......
Simian virus 40 (SV40), a member of the Polyomaviridae family, stands as one of the most extensively studied and historically significant viruses in molecular biology. Discovered in 1960 as a contaminant of poliovirus vaccines produced in rhesus monkey kidney cells, SV40 has served as a cornerstone for understanding fundamental cellular processes including DNA replication, transcription, RNA splicing, and cellular transformation. For over six decades, this small DNA tumor virus has provided researchers with an elegant model system to dissect the intricate molecular interactions between viruses and their host cells. The natural host of SV40 is the rhesus macaque, in which the virus establishes persistent, asymptomatic infections primarily in kidney epithelium. However, in non-permissive hosts such as rodents, and under certain conditions in human cells, SV40 exhibits remarkable oncogenic potential, driving cellular transformation through the actions of its multifunctional early region proteins.
Figure 1. An overview of the Simian Virus 40 (SV40) cell entry process. (Toscano M G, et al. 2018)
SV40 is the prototypic member of the genus Betapolyomavirus within the family Polyomaviridae, closely related to human pathogens BK virus (BKV) and JC virus (JCV). The virus possesses a small, circular double-stranded DNA genome of approximately 5.2 kilobase pairs, organised into three functional regions: early, late, and regulatory. The genome is complexed with cellular histones to form a minichromosome structure within the virion, mimicking host chromatin organisation. The early region encodes three tumour antigens—large T antigen (LT), small T antigen (ST), and 17KT—produced through alternative splicing of a common primary transcript. These proteins share the N-terminal 82 residues, which contain a conserved J domain homologous to cellular DnaJ/Hsp40 molecular chaperones. LT is a multifunctional phosphoprotein of 708 amino acids that drives viral DNA replication, regulates transcription, and subverts host cell cycle controls. ST, a 174-residue protein, modulates cellular signalling pathways, while 17KT, a 135-residue isoform, remains less characterised but contributes to transformation.
Clinical manifestations of SV infection vary by viral species, host species, and immune status. In their natural primate hosts, many SVs cause mild or subclinical infections. For example, SV40 infection in rhesus monkeys is typically asymptomatic, while SIV infection in African green monkeys and sooty mangabeys is often non-pathogenic, with no signs of immunodeficiency.
In contrast, zoonotic SV infections in humans can be severe. B virus infection in humans causes acute encephalitis, with symptoms including fever, headache, muscle pain, and neurological deficits, leading to death in 70–80% of untreated cases. SIV does not naturally infect humans, but its close relative HIV (derived from SIV) causes acquired immunodeficiency syndrome (AIDS). SV40 has been linked to human cancers (e.g., mesothelioma, brain tumors) in some studies, though its role in oncogenesis remains controversial.
Detecting simian viruses requires a combination of molecular and serological techniques. In laboratory and zoo settings, routine screening is vital for both animal welfare and researcher safety.
SV40's ability to transform non-permissive cells has provided an unparalleled model for understanding cancer mechanisms. In permissive monkey cells, infection leads to lytic replication and cell death. However, in non-permissive rodent cells and semi-permissive human cells, the replication cycle is blocked at viral DNA synthesis, allowing T antigen expression to drive stable transformation. LT-mediated transformation requires binding to both Rb and p53; mutants unable to interact with either tumour suppressor fail to transform primary cells. ST cooperates by inhibiting PP2A, promoting survival and proliferation signals. The resulting transformed cells exhibit hallmark cancer phenotypes including immortalisation, loss of contact inhibition, anchorage-independent growth, and tumour formation in animal models. Transgenic mice expressing SV40 T antigens under tissue-specific promoters have become invaluable tools for studying cancer development in various organs, including prostate, mammary gland, and liver.
Simian virus 40 stands as one of the most consequential viruses in the history of biomedical research. Its study has illuminated fundamental principles of DNA replication, transcription, RNA processing, and cellular transformation. Key molecular targets—including the viral T antigens, tumour suppressors p53 (TP53) and Rb (RB1), protein phosphatase PP2A, ER chaperones DNAJB12, DNAJB14, and DNAJC18, signalling molecules PLCG1, AKT1, PARP1, ILK, and RhoA, and numerous additional host partners—provide a comprehensive map of virus-host interactions that drive pathogenesis and oncogenesis. The discovery of p53 as an SV40 LT-binding protein exemplifies how studying a simple DNA tumour virus can reveal central players in human cancer. As research continues, SV40 remains a powerful model for dissecting the epigenetic regulation of viral chromatin, the coexistence of functionally distinct viral chromosomes in infected cells, and the evolutionary arms race between viruses and their hosts. The legacy of this "historic virus" endures, informing contemporary virology, cancer biology, and the development of viral vectors for gene therapy and vaccination.
Reference
| Target | Cat. No. | Product Name | Host | Isotype | Application | |
| V5 Tag | CABT-NS1208 | Human Anti-Paramyxovirus Simian Virus V5 epitope tag Monoclonal Antibody, clone SV5-P-K | Human | F(ab)2 | IP, RIA, WB, ELISA, IF, IHC-Fr | Inquiry |
| Target | Cat. No. | Product Name | Host | |
| SV40 VP1 | DAG-P2866 | Simian Virus type 40 Major Capsid VP1 (full length) | S. cerevisiae | Inquiry |
| SV40 Large T Antigen | DAGC100 | Recombinant Simian Virus 40 Large Antigen [His] | Insect Cells | Inquiry |
Loading ......
